280 related articles for article (PubMed ID: 32246006)
1. Transcriptomic features of tumour-infiltrating CD4
Parrot T; Oger R; Allard M; Desfrançois J; Raingeard de la Blétière D; Coutolleau A; Preisser L; Khammari A; Dréno B; Delneste Y; Guardiola P; Fradin D; Gervois N
Sci Rep; 2020 Apr; 10(1):5900. PubMed ID: 32246006
[TBL] [Abstract][Full Text] [Related]
2. IL-9 promotes the survival and function of human melanoma-infiltrating CD4(+) CD8(+) double-positive T cells.
Parrot T; Allard M; Oger R; Benlalam H; Raingeard de la Blétière D; Coutolleau A; Preisser L; Desfrançois J; Khammari A; Dréno B; Labarrière N; Delneste Y; Guardiola P; Gervois N
Eur J Immunol; 2016 Jul; 46(7):1770-82. PubMed ID: 27094152
[TBL] [Abstract][Full Text] [Related]
3. CD40L confers helper functions to human intra-melanoma class-I-restricted CD4
Parrot T; Oger R; Benlalam H; Raingeard de la Blétière D; Jouand N; Coutolleau A; Preisser L; Khammari A; Dréno B; Guardiola P; Delneste Y; Labarrière N; Gervois N
Oncoimmunology; 2016; 5(12):e1250991. PubMed ID: 28123891
[TBL] [Abstract][Full Text] [Related]
4. Aberrant Expression of MHC Class II in Melanoma Attracts Inflammatory Tumor-Specific CD4+ T- Cells, Which Dampen CD8+ T-cell Antitumor Reactivity.
Donia M; Andersen R; Kjeldsen JW; Fagone P; Munir S; Nicoletti F; Andersen MH; Thor Straten P; Svane IM
Cancer Res; 2015 Sep; 75(18):3747-59. PubMed ID: 26183926
[TBL] [Abstract][Full Text] [Related]
5. Runx3 regulates integrin alpha E/CD103 and CD4 expression during development of CD4-/CD8+ T cells.
Grueter B; Petter M; Egawa T; Laule-Kilian K; Aldrian CJ; Wuerch A; Ludwig Y; Fukuyama H; Wardemann H; Waldschuetz R; Möröy T; Taniuchi I; Steimle V; Littman DR; Ehlers M
J Immunol; 2005 Aug; 175(3):1694-705. PubMed ID: 16034110
[TBL] [Abstract][Full Text] [Related]
6. Extrathymic CD4/CD8 double positive T cells.
Zuckermann FA
Vet Immunol Immunopathol; 1999 Dec; 72(1-2):55-66. PubMed ID: 10614493
[TBL] [Abstract][Full Text] [Related]
7. Runx3 programs CD8
Milner JJ; Toma C; Yu B; Zhang K; Omilusik K; Phan AT; Wang D; Getzler AJ; Nguyen T; Crotty S; Wang W; Pipkin ME; Goldrath AW
Nature; 2017 Dec; 552(7684):253-257. PubMed ID: 29211713
[TBL] [Abstract][Full Text] [Related]
8. Checkpoint blockade immunotherapy enhances the frequency and effector function of murine tumor-infiltrating T cells but does not alter TCRβ diversity.
Kuehm LM; Wolf K; Zahour J; DiPaolo RJ; Teague RM
Cancer Immunol Immunother; 2019 Jul; 68(7):1095-1106. PubMed ID: 31104075
[TBL] [Abstract][Full Text] [Related]
9. Single-Cell Transcriptomic Analysis Reveals a Tumor-Reactive T Cell Signature Associated With Clinical Outcome and Immunotherapy Response In Melanoma.
Yan M; Hu J; Ping Y; Xu L; Liao G; Jiang Z; Pang B; Sun S; Zhang Y; Xiao Y; Li X
Front Immunol; 2021; 12():758288. PubMed ID: 34804045
[TBL] [Abstract][Full Text] [Related]
10. An Integrated Epigenomic and Transcriptomic Map of Mouse and Human αβ T Cell Development.
Chopp LB; Gopalan V; Ciucci T; Ruchinskas A; Rae Z; Lagarde M; Gao Y; Li C; Bosticardo M; Pala F; Livak F; Kelly MC; Hannenhalli S; Bosselut R
Immunity; 2020 Dec; 53(6):1182-1201.e8. PubMed ID: 33242395
[TBL] [Abstract][Full Text] [Related]
11. A Population of CD4
Yu ED; Wang H; da Silva Antunes R; Tian Y; Tippalagama R; Alahakoon SU; Premawansa G; Wijewickrama A; Premawansa S; De Silva AD; Frazier A; Grifoni A; Sette A; Weiskopf D
Viruses; 2022 Jan; 14(1):. PubMed ID: 35062294
[TBL] [Abstract][Full Text] [Related]
12. Diminution of the AML1 transcription factor function causes differential effects on the fates of CD4 and CD8 single-positive T cells.
Hayashi K; Natsume W; Watanabe T; Abe N; Iwai N; Okada H; Ito Y; Asano M; Iwakura Y; Habu S; Takahama Y; Satake M
J Immunol; 2000 Dec; 165(12):6816-24. PubMed ID: 11120804
[TBL] [Abstract][Full Text] [Related]
13. Detection and characterization of a novel subset of CD8⁺CD57⁺ T cells in metastatic melanoma with an incompletely differentiated phenotype.
Wu RC; Liu S; Chacon JA; Wu S; Li Y; Sukhumalchandra P; Murray JL; Molldrem JJ; Hwu P; Pircher H; Lizée G; Radvanyi LG
Clin Cancer Res; 2012 May; 18(9):2465-77. PubMed ID: 22307139
[TBL] [Abstract][Full Text] [Related]
14. Canine peripheral non-conventional TCRαβ
Protschka M; Di Placido D; Moore PF; Büttner M; Alber G; Eschke M
Front Immunol; 2024; 15():1400550. PubMed ID: 38835756
[TBL] [Abstract][Full Text] [Related]
15. Topical treatment of all-trans retinoic acid inhibits murine melanoma partly by promoting CD8
Yin W; Song Y; Liu Q; Wu Y; He R
Immunology; 2017 Oct; 152(2):287-297. PubMed ID: 28556970
[TBL] [Abstract][Full Text] [Related]
16. Age-dependent accumulation of monoclonal CD4+CD8+ double positive T lymphocytes in the peripheral blood of the elderly.
Ghia P; Prato G; Stella S; Scielzo C; Geuna M; Caligaris-Cappio F
Br J Haematol; 2007 Dec; 139(5):780-90. PubMed ID: 18021092
[TBL] [Abstract][Full Text] [Related]
17. Lineage re-commitment of CD4CD8αα intraepithelial lymphocytes in the gut.
Park Y; Moon SJ; Lee SW
BMB Rep; 2016 Jan; 49(1):11-7. PubMed ID: 26592937
[TBL] [Abstract][Full Text] [Related]
18. Absence of amplification of CD4+CD25(high) regulatory T cells during in vitro expansion of tumor-infiltrating lymphocytes in melanoma patients.
Knol AC; Lemaître F; Pandolfino MC; Volteau C; Quéreux G; Saiagh S; Khammari A; Viguier M; Dréno B
Exp Dermatol; 2008 May; 17(5):436-45. PubMed ID: 18312383
[TBL] [Abstract][Full Text] [Related]
19. Functional Heterogeneity of CD4
Oja AE; Piet B; van der Zwan D; Blaauwgeers H; Mensink M; de Kivit S; Borst J; Nolte MA; van Lier RAW; Stark R; Hombrink P
Front Immunol; 2018; 9():2654. PubMed ID: 30505306
[TBL] [Abstract][Full Text] [Related]
20. Functionally mature CD4 and CD8 TCRalphabeta cells are generated in OP9-DL1 cultures from human CD34+ hematopoietic cells.
Van Coppernolle S; Verstichel G; Timmermans F; Velghe I; Vermijlen D; De Smedt M; Leclercq G; Plum J; Taghon T; Vandekerckhove B; Kerre T
J Immunol; 2009 Oct; 183(8):4859-70. PubMed ID: 19801512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
